Michael J. Doherty, Head of Product Development at Foundation Medicine, Inc. (FMI), sold 5,350 shares at $136.66 ($731K) on 2018-07-02, disclosed to the SEC on 2018-07-05.
Open-market sale of $731k FMI by Head of Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.66 | 2,675 | $366K | 50.0% |
| 2 | $136.66 | 2,675 | $366K | 50.0% |
| Total | $136.66 avg | 5,350 | $731K | 100% |
| Filing → |